Business Context and Reporting Period
Company: SmartKem, Inc. (SMTK)
Filing Type: Form 8-K (Current Report)
Date of Report: March 30, 2026
Reporting Period: Events occurring on March 30, 2026, regarding capital raising activities and Nasdaq compliance.
Key Financial Metrics and Capital Structure
This filing details a significant capital raise rather than operational financial results. Key metrics include:
- Private Placement Proceeds: Expected gross proceeds of $9,129,200.
- Series A Preferred Stock: 11,411.5 shares issued with a stated value of $1,000 per share ($11,411,500 total stated value).
- Warrants Issued: Warrants to purchase up to 23,251,960 shares of Common Stock.
- Conversion/Exercise Price: Initial price of $0.5812 per share for both Preferred Stock conversion and Warrant exercise.
- Debt Exchange: $3,750,000 of previously issued senior secured promissory notes (March Notes) exchanged for securities valued at 120% of principal ($4,500,000).
- Equity Line of Credit (ELOC): Agreement to sell up to $500,000,000 or 19.99% of outstanding Common Stock (whichever is less) at 90% of VWAP.
- Consulting Fees: Company required to retain a consultant for up to $240,000.
Material Changes Versus Prior Period
The filing represents a material change in the company's capital structure and regulatory status:
- Capitalization: Transition from a debt-heavy structure (March Notes) to a hybrid equity/debt structure via the Series A Preferred Stock and Warrants.
- Authorized Shares: Proposed increase in authorized Common Stock from 300,000,000 to 5,000,000,000 pending stockholder approval.
- Nasdaq Compliance: The company previously received a delisting notice on August 15, 2025, for failing to meet the $2.5 million stockholders' equity requirement. Management states the Private Placement has restored equity to at least $2.5 million, though formal confirmation from Nasdaq is pending.
- Restrictions: New prohibitions on issuing equity below the conversion price ($0.5812) and restrictions on dividends or stock splits without Buyer consent for up to three years.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Use of Proceeds: Net proceeds from the Private Placement are intended for working capital and general corporate purposes. The company expects the closing to occur around March 31, 2026.
Stockholder Approval Requirements: The company must obtain stockholder approval within 45 to 60 days for:
- Increase in authorized shares.
- Removal of restrictions on stockholder action by written consent.
- Issuance of securities under the Preferred Stock Purchase Agreement.
- A reverse stock split (ratio to be determined).
- Increase in shares under the 2021 Equity Incentive Plan.
Risks and Contingencies:
- Delisting Risk: While the company believes it has regained compliance, Nasdaq will continue to monitor the situation. Failure to evidence compliance in the next periodic report could result in delisting.
- Dilution: The issuance of Series A Preferred Stock, Warrants, and the ELOC commitment shares (10,000 shares) creates significant potential dilution. The Warrants include full ratchet anti-dilution protection.
- Registration Penalties: The company faces cash penalties if it fails to file and declare effective registration statements for the resale of securities within specified timelines (60-120 days).
- Dividend Accrual: Series A Preferred Stock carries a 15.0% per annum default dividend rate upon the occurrence of a triggering event.
Investor Verification Checklist
- Verify the effectiveness of the registration statement for the resale of Series A Preferred Stock and Warrants.
- Confirm the outcome of the Nasdaq Hearings Panel regarding the delisting notice and the company's current listing status.
- Monitor the timeline for the required stockholder vote on the increase in authorized shares and the reverse stock split.
- Review the specific terms of the "triggering events" that would activate the 15% default dividend on the Series A Preferred Stock.
- Assess the impact of the ELOC agreement on future share issuance and potential dilution, noting the 90% of VWAP pricing mechanism.